Mood and impulsivity of recreational Ecstasy users in the week following a “rave”

References

• Adamson, S., & Metzner, R. (1988). The nature of the MDMA experience and its role in healing, psychotherapy, and spiritual practice. The Journal of Consciousness and Change, 10(4), 120–137.
   Google Scholar
• American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington DC: American Psychiatric Association.
   Google Scholar
• Australian Institute of Health and Welfare (AIHW) (2003). Statistics on drug use in Australia 2002. Canberra, Australia: AIHW.
   Google Scholar
• Barker, B., Bradnam, J., Meyer, S., & Lyvers, M. (2003). Neuropsychological performance of human ecstasy users. Presented at the 17th World Congress on Psychosomatic Medicine, Waikoloa, Hawaii, August 2003.
   Google Scholar
• Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory: Manual. San Antonio, Texas: Psychological Corporation.
   Google Scholar
• Boot, B. P., McGregor, I. S., & Hall, W. (2000). MDMA (Ecstasy) neurotoxicity: Assessing and communication risks. Lancet, 355, 1818–1821.
   PubMed Web of Science ®Google Scholar
• Brown, C., Schulberg, H., & Madonia, M. (1995). Assessing depression in primary care practice with the Beck depression inventory and the Hamilton rating scale for depression. Psychological Assessment, 7, 59–65.
   Web of Science ®Google Scholar
• Callow, N. (1996). Use of the ‘snowballing’ technique to investigate subjective mood and personality traits associated with ‘Ecstasy’. Proceedings of the British Psychological Society, 4(2), 65.
   Google Scholar
• Cole, J. C., & Sumnall, H. R. (2003). Altered states: The clinical effects of ecstasy. Pharmacology & Therapeutics, 98, 35–58.
   PubMed Web of Science ®Google Scholar
• Curran, H. V., & Travill, R. A. (1997). Mood and cognitive effects of 3, 4-methylenedioxymetham- phetamine (MDMA): Weekend ‘high’ followed by mid-week low. Addiction, 92, 529–548.
   Google Scholar
• Diemel, S., & Blanken, P. (1999). Tracking new trends in drug use. Journal of Drug Issues, 29, 529–548.
   Web of Science ®Google Scholar
• Dozois, D. J., Dobson, K. S., & Ahnberg, J. (1998). A psychometric evaluation of the Beck Depression Inventory-II. Psychological Assessment, 5, 150–155.
   Google Scholar
• Eysenck, H., & Eysenck, S. (1991). Eysenck personality questionnaire (EPQ): Adult. London: Hodder & Stroughton.
   Google Scholar
• Gamma, A., Frei, E., Lehmann, D., Pascual-Marqui, R. D., Hell, D., & Vollenweider, F. X. (2000). Mood state and brain electric activity in ecstasy users. Clinical Neuroscience and Neuropsychology, 11(1), 157–162.
   Google Scholar
• Gerra, G., Zaimovic, G., Guicastro, D., & Maestri, D. (1998). Serotonergic function after 3, 4-methylene- dioxymethamphetamine (‘Ecstasy’) in humans. International Clinical Psychopharmacology, 13, 1–9.
   PubMed Web of Science ®Google Scholar
• Greer, G., & Tolbert, R. (1986). Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs, 18(4), 319–327.
   PubMed Web of Science ®Google Scholar
• Halpern, J. H., Pope, H. G., Sherwood, A. R., Barry, S., Hudson, J. I., & Yurgelun-Todd, D. (2004). Residual neuropsychological effects of illicit 3,4-methelenedioxy-methamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence, 75, 135–147.
   PubMed Web of Science ®Google Scholar
• Hammersley, R., Ditton, J., Smith, I., & Short, E. (1999). Patterns of ecstasy use by drug users. The British Journal of Criminology, 39(4), 625–647.
   Web of Science ®Google Scholar
• Irvine, R., Keane, M., Felgate, P., Callaghan, P., & White, J. (2003). Blood drug concentrations and clinical status of dance party participants. Presented at the Annual Meeting of the Australasian Society of Clinical & Experimental Pharmacologists and Toxicologists, Sydney, Australia, December 2003.
   Google Scholar
• Krystal, J. H., & Price, L. H. (1992). Chronic 3, 4-methylenedioxymethamphetamine (MDMA) use: Effects on mood and neuropsychological function. American Journal of Drug and Alcohol Abuse, 18(3), 331–341.
   Google Scholar
• Linnoila, M., Virkkunen, M., George, T., & Higley, D. (1993). Impulse control disorders. International Clinical Psychopharmacology, 8, 53–56.
   Web of Science ®Google Scholar
• Lyvers, M., & Hasking, P. (2004). Have Halpern et al. (2004) detected ‘residual neuropsychological effects’ of MDMA? Not likely. Drug & Alcohol Dependence, 75, 149–152.
   Google Scholar
• Martin, D. (1999). Power play and party politics: The significance of raving. Journal of Popular Culture, 32(4), 77–99.
   Web of Science ®Google Scholar
• McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994). Serotonin neurotoxicity after 3, 4-methylenedioxymethamphetamine (MDMA; ‘‘Ecstasy’’): A controlled study in humans. Neuropsychopharmacology, 10(2), 129–137.
   PubMed Web of Science ®Google Scholar
• Morgan, M. J. (1998). Recreational use of ‘‘Ecstasy’’ (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19(4), 252–264.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C. (2004). Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity. Psychopharmacology (Berl), 173(3–4), 234–41.
   Google Scholar
• Parrott, A. C., & Lasky, J. (1998). Ecstasy (MDMA) effects upon mood and cognition: Before, during and after a saturday night dance. Psychopharmacology, 139, 261–268.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., Sisk, E., & Turner, J. J. (2000). Psychobiological problems in heavy ‘‘Ecstasy’’ (MDMA) ploydrug users. Drug and Alcohol Dependence, 60, 105–110.
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., & Stuart, M. (1997). Ecstasy (MDMA), amphetamine and LSD: Comparative mood profiles in recreational polydrug users. Human Psychopharmacology, 12, 501–504.
   Web of Science ®Google Scholar
• Peroutka, S. J., Newman, H., & Harris, H. (1998). Subjective effects of 3, 4-methylenedioxymethampheta- mine in recreational users. Neuropsychopharmacology, 1(4), 273–277.
   Google Scholar
• Saunders, N. (1995). Spiritual uses of MDMA in traditional religion. Multidisciplinary Association of Psychedelic Studies Bulletin, 6, 80–87.
   Google Scholar
• Solowij, N., Hall, W., & Lee, N. (1992). Recreational MDMA use in Sydney: A profile of ‘Ecstasy’ users and their experience with the drug. British Journal of Addiction, 87, 1161–1172.
   PubMedGoogle Scholar
• Soubrie, P. (1986). Reconciling the role of central serotonin neurons in human and animal behaviour. Behavioural and Brain Sciences, 9, 319–364.
   Web of Science ®Google Scholar
• Staley, J. K., Malison, R. T., & Innis, R. B. (1998). Imaging of the serotonergic system: Interactions of neuroanatomical and functional abnormalities of depression. Biological Psychiatry, 44, 534–549.
   PubMed Web of Science ®Google Scholar
• Topp, L., Hando, J., Dillon, P., Roche, A., & Solowij, N. (1999). Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence, 55, 105–115.
   PubMed Web of Science ®Google Scholar
• Virkkunen, M., & Linnoila, M. (1993). Brain serotonin, type II alcoholism and impulsive violence. Journal of Studies on Alcoholism, 11, 163–169.
   Google Scholar
• Wijngaart, V., Braam, R., Bruin, D., & Fris, M. (1999). Ecstasy use at large-scale dance events in the Netherlands. Journal of Drug Issues, 29(3), 279–701.
   Google Scholar
• Zuckerman, M., Kuhlman, D. M., & Camac, C. (1988). What lies beyond E and N? Factor analyses of scales believed to measure basic dimensions of personality. Journal of Personality and Social Psychology, 54, 96–107.
   Web of Science ®Google Scholar